Weixue Wang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Tyrosine Kinase

Structural Basis

Top Venues

ACS medicinal chemistry letters

Cancer discovery

Janssen Research and Development

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Janssen Research and Development May 11 2015

United States

Senior Scientist :: Molecular and Cellular Pharmacology

Massachusetts Institute of Technology Jul 02 2012 - Mar 31 2015

United States

Postdoctoral Associate :: Chemistry

Publications

Leonard Buckbinder, David J St Jean, Trang Tieu, Brendon Ladd, Brendan J Hilbert, Weixue Wang, Jacob T Alltucker, Samantha Manimala, Gregory V Kryukov, Natasja Brooijmans, Gregory Dowdell, Philip Jonsson, Michael Huff, Angel Guzman-Perez, Erica L Jackson, Marcus DaSilva Goncalves, Darrin D Stuart
STX-478, a Mutant-Selective, Allosteric PI3Ka Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Ka-Mutant Xenografts. Cancer discovery (2023)
Mark S Tichenor, John J M Wiener, Navin L Rao, Charlotte Pooley Deckhut, J Kent Barbay, Kevin D Kreutter, Genesis M Bacani, Jianmei Wei, Leon Chang, Heather E Murrey, Weixue Wang, Kay Ahn, Michael Huber, Elizabeth Rex, Kevin J Coe, JieJun Wu, Mark J Seierstad, Scott D Bembenek, Kristi A Leonard, Alec D Lebsack, Jennifer D Venable, James P Edwards
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory Activity. ACS medicinal chemistry letters 12 (5) (2021)
Weixue Wang, Daniel Krosky, Kay Ahn
Discovery of Inactive Conformation-Selective Kinase Inhibitors by Utilizing Cascade Assays. Biochemistry 56 (34) (2017)